Friday, April 15, 2022

The rigged presidential debates are over

It took the GOP long enough to wise up, but it finally happened.

Are Democrats going to get crushed in November?

 President Biden is deep underwater in polls of adults. Likely voters usually lean more R.

 


Bidenflation is going to make this worse.

Saturday, March 26, 2022

If you give soldiers proper informed consent, how many agree to the covid vaccine? Almost none...

Sunday, March 20, 2022

Brilliant: Scott Presler registers voters at Republican at gas pumps.

Saturday, March 19, 2022

Alleged video of Russian hyper-sonic missile in Ukraine

Sunday, March 13, 2022

Flashback: Biden made a campaign promise to end all drilling. (Video)

 

Covid vaccines have limited effect against Omnicron and after 20 weeks there is almost no effect. (Study)

From: The New England Journal Of Medicine

Results

Between November 27, 2021, and January 12, 2022, a total of 886,774 eligible persons infected with the omicron variant, 204,154 eligible persons infected with the delta variant, and 1,572,621 eligible test-negative controls were identified. At all time points investigated and for all combinations of primary course and booster vaccines, vaccine effectiveness against symptomatic disease was higher for the delta variant than for the omicron variant. No effect against the omicron variant was noted from 20 weeks after two ChAdOx1 nCoV-19 doses, whereas vaccine effectiveness after two BNT162b2 doses was 65.5% (95% confidence interval [CI], 63.9 to 67.0) at 2 to 4 weeks, dropping to 8.8% (95% CI, 7.0 to 10.5) at 25 or more weeks. Among ChAdOx1 nCoV-19 primary course recipients, vaccine effectiveness increased to 62.4% (95% CI, 61.8 to 63.0) at 2 to 4 weeks after a BNT162b2 booster before decreasing to 39.6% (95% CI, 38.0 to 41.1) at 10 or more weeks. Among BNT162b2 primary course recipients, vaccine effectiveness increased to 67.2% (95% CI, 66.5 to 67.8) at 2 to 4 weeks after a BNT162b2 booster before declining to 45.7% (95% CI, 44.7 to 46.7) at 10 or more weeks. Vaccine effectiveness after a ChAdOx1 nCoV-19 primary course increased to 70.1% (95% CI, 69.5 to 70.7) at 2 to 4 weeks after an mRNA-1273 booster and decreased to 60.9% (95% CI, 59.7 to 62.1) at 5 to 9 weeks. After a BNT162b2 primary course, the mRNA-1273 booster increased vaccine effectiveness to 73.9% (95% CI, 73.1 to 74.6) at 2 to 4 weeks; vaccine effectiveness fell to 64.4% (95% CI, 62.6 to 66.1) at 5 to 9 weeks.

Conclusions

Primary immunization with two doses of ChAdOx1 nCoV-19 or BNT162b2 vaccine provided limited protection against symptomatic disease caused by the omicron variant. A BNT162b2 or mRNA-1273 booster after either the ChAdOx1 nCoV-19 or BNT162b2 primary course substantially increased protection, but that protection waned over time. (Funded by the U.K. Health Security Agency.)

 

Ukrainian Conflict - Tank Recognition (Information for the Biden years)

Ukrainian Conflict - Tank Recognition

 

 

Too soon?

https://amzn.to/3J7rIVL